Pier Ferruccio Ballerini
Overview
Explore the profile of Pier Ferruccio Ballerini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salvarani C, Dolci G, Massari M, Merlo D, Cavuto S, Savoldi L, et al.
JAMA Intern Med
. 2020 Oct;
181(1):24-31.
PMID: 33080005
Importance: The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of people worldwide. Tocilizumab has shown promising results in retrospective studies in patients with COVID-19 pneumonia with a good safety...
2.
Lombardi A, Berti De Marinis G, Scandellari R, Magalini F, Sansoni P, Ballerini P, et al.
Thromb Res
. 2010 Mar;
126(2):e154-6.
PMID: 20193960
No abstract available.
3.
Corazzelli G, Capobianco G, Arcamone M, Ballerini P, Iannitto E, Russo F, et al.
Cancer Chemother Pharmacol
. 2009 Feb;
64(5):907-16.
PMID: 19219604
Purpose: To determine the efficacy and safety of the combination of gemcitabine plus oxaliplatin, with and without rituximab, in patients with relapsed/refractory B-cell lymphoma unsuitable for high dose therapy. Methods:...
4.
Degan M, Rupolo M, Dal Bo M, Stefanon A, Bomben R, Zucchetto A, et al.
Clin Lymphoma
. 2004 Sep;
5(2):123-6.
PMID: 15453928
Mutational status of immunoglobulin heavy-chain variable-region (IgVH) genes, along with CD38 expression, is a prognostic marker in B-cell chronic lymphocytic leukemia (B-CLL). Configuration of IgVH genes displaying > 2% mismatch...
5.
Degan M, Bomben R, Dal Bo M, Zucchetto A, Nanni P, Rupolo M, et al.
Br J Haematol
. 2004 Jun;
126(1):29-42.
PMID: 15198729
Cases of B-cell chronic lymphocytic leukaemia (B-CLL) with mutated (M) IgV(H) genes have a better prognosis than unmutated (UM) cases. We analysed the IgV(H) mutational status of B-CLL according to...